Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum Uric Acid Is Associated with Incident Chronic Kidney Disease in Middle-Aged Populations: A Meta-Analysis of 15 Cohort Studies
Ping Zhu, Yan Liu, Lu Han, et al.
PLoS ONE (2014) Vol. 9, Iss. 6, pp. e100801-e100801
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
Richard J. Johnson, George L. Bakris, Claudio Borghi, et al.
American Journal of Kidney Diseases (2018) Vol. 71, Iss. 6, pp. 851-865
Open Access | Times Cited: 533
Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9221-9221
Open Access | Times Cited: 345
Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies
Xue Li, Xiangrui Meng, Maria Timofeeva, et al.
BMJ (2017), pp. j2376-j2376
Open Access | Times Cited: 301
New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity
Masato Furuhashi
AJP Endocrinology and Metabolism (2020) Vol. 319, Iss. 5, pp. E827-E834
Closed Access | Times Cited: 246
The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD
Yuka Sato, Daniel I. Feig, Austin G. Stack, et al.
Nature Reviews Nephrology (2019) Vol. 15, Iss. 12, pp. 767-775
Closed Access | Times Cited: 163
Uric Acid and Chronic Kidney Disease: Still More to Do
Richard J. Johnson, Laura Gabriela Sánchez‐Lozada, Miguel A. Lanaspa, et al.
Kidney International Reports (2022) Vol. 8, Iss. 2, pp. 229-239
Open Access | Times Cited: 77
Emerging Liver–Kidney Interactions in Nonalcoholic Fatty Liver Disease
Giovanni Musso, Maurizio Cassader, S. Cohney, et al.
Trends in Molecular Medicine (2015) Vol. 21, Iss. 10, pp. 645-662
Closed Access | Times Cited: 114
Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia: 3‐year randomized parallel‐controlled study
Peng Liu, Yingying Chen, Bin Wang, et al.
Clinical Endocrinology (2014) Vol. 83, Iss. 4, pp. 475-482
Closed Access | Times Cited: 113
Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease
Hitoshi Nishizawa, Norikazu Maeda, Iichiro Shimomura
Hypertension Research (2022) Vol. 45, Iss. 4, pp. 635-640
Closed Access | Times Cited: 62
Association of Uric Acid–Lowering Therapy With Incident Chronic Kidney Disease
Waleed Hassan, Prabin Shrestha, Keiichi Sumida, et al.
JAMA Network Open (2022) Vol. 5, Iss. 6, pp. e2215878-e2215878
Open Access | Times Cited: 46
Dotinurad treatment for patients with hyperuricemia complicating chronic kidney disease
Katsuyuki Tanabe, Tomokazu Nunoue, Naoki Itabashi, et al.
Kidney International Reports (2025)
Open Access | Times Cited: 1
Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus
Vendula Bartáková, Katarína Kuricová, Lukáš Pácal, et al.
Journal of Diabetes and its Complications (2016) Vol. 30, Iss. 7, pp. 1300-1307
Closed Access | Times Cited: 67
How should we manage asymptomatic hyperuricemia?
Gérard Chalès
Joint Bone Spine (2018) Vol. 86, Iss. 4, pp. 437-443
Closed Access | Times Cited: 66
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project
Elisa Russo, Francesca Viazzi, Roberto Pontremoli, et al.
Journal of Nephrology (2021) Vol. 35, Iss. 1, pp. 211-221
Open Access | Times Cited: 53
JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease
Akira Fujiyoshi, Shun Kohsaka, Jun Hata, et al.
Circulation Journal (2024) Vol. 88, Iss. 5, pp. 763-842
Open Access | Times Cited: 7
Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease—A Propensity Score Analysis
Shunya Uchida, Wenxiu Chang, Tatsuru Ota, et al.
PLoS ONE (2015) Vol. 10, Iss. 12, pp. e0145506-e0145506
Open Access | Times Cited: 52
Uric Acid as a Risk Factor for Chronic Kidney Disease and Cardiovascular Disease ― Japanese Guideline on the Management of Asymptomatic Hyperuricemia ―
Ichiro Hisatome, Peili Li, Junichiro Miake, et al.
Circulation Journal (2020) Vol. 85, Iss. 2, pp. 130-138
Open Access | Times Cited: 42
U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2
Kazuma Mori, Masato Furuhashi, Marenao Tanaka, et al.
Hypertension Research (2020) Vol. 44, Iss. 1, pp. 107-116
Closed Access | Times Cited: 41
Risk Factors for Hyperuricemia or Gout in Men and Women: The Circulatory Risk in Communities Study (CIRCS)
Saki Teramura, Kazumasa Yamagishi, Mitsumasa Umesawa, et al.
Journal of Atherosclerosis and Thrombosis (2023) Vol. 30, Iss. 10, pp. 1483-1491
Open Access | Times Cited: 16
ABCG2: the molecular mechanisms of urate secretion and gout
Owen M. Woodward
AJP Renal Physiology (2015) Vol. 309, Iss. 6, pp. F485-F488
Open Access | Times Cited: 41
Serum uric acid and the incidence of CKD and hypertension
Satoru Kuriyama, Yukio Maruyama, Shinichiro Nishio, et al.
Clinical and Experimental Nephrology (2015) Vol. 19, Iss. 6, pp. 1127-1134
Open Access | Times Cited: 41
High prevalence of chronic kidney disease and its related risk factors in rural areas of Northeast Thailand
Ubon Cha’on, Patcharaporn Tippayawat, Nattaya Sae‐ung, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Association between serum uric acid/HDL-cholesterol ratio and chronic kidney disease: a cross-sectional study based on a health check-up population
Yang Cheng, Hao Zhang, Hui Zheng, et al.
BMJ Open (2022) Vol. 12, Iss. 12, pp. e066243-e066243
Open Access | Times Cited: 21
Association of hyperuricemia with cardiovascular diseases: current evidence
Steven G. Chrysant
Hospital Practice (2023) Vol. 51, Iss. 2, pp. 54-63
Closed Access | Times Cited: 13
Serum uric acid levels and health outcomes in CKD: a prospective cohort study
Shijie Wu, Wen Xue, Hanqing Yu, et al.
Nephrology Dialysis Transplantation (2023) Vol. 39, Iss. 3, pp. 510-519
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top